BioCentury
ARTICLE | Clinical News

AVN-211: Phase IIb data

August 24, 2015 7:00 AM UTC

A double-blind, Russian Phase IIb trial in 80 schizophrenic patients in incomplete remission on stable antipsychotic therapy showed that once-daily oral AVN-211 missed the primary endpoint of improvin...